Home » Stocks » XTNT

Xtant Medical Holdings, Inc. (XTNT)

Stock Price: $1.17 USD -0.19 (-14.12%)
Updated Oct 30, 2020 2:58 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 84.09M
Revenue (ttm) 57.99M
Net Income (ttm) -8.44M
Shares Out 72.00M
EPS (ttm) -0.65
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 30, 2020
Last Price $1.17
Previous Close $1.36
Change ($) -0.19
Change (%) -14.12%
Day's Open 1.26
Day's Range 1.12 - 1.31
Day's Volume 208,163
52-Week Range 0.55 - 3.50

More Stats

Market Cap 84.09M
Enterprise Value 160.63M
Earnings Date (est) Mar 11, 2021
Ex-Dividend Date n/a
Shares Outstanding 72.00M
Float 70.76M
EPS (basic) -0.65
EPS (diluted) -0.65
FCF / Share -0.30
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 583,839
Short Ratio 0.09
Short % of Float 0.83%
Beta 1.58
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 1.45
PB Ratio n/a
Revenue 57.99M
Operating Income -2.77M
Net Income -8.44M
Free Cash Flow -4.01M
Net Cash -76.54M
Net Cash / Share -1.06
Gross Margin 73.31%
Operating Margin -4.78%
Profit Margin -14.60%
FCF Margin -6.91%
ROA -2.86%
ROE n/a
ROIC -2.60%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (1)

Buy 0
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Hold

Price Target

$1.00*
Low
1.00
Current: $1.17
High
1.00
Target: 1.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue64.6872.2082.6190.0059.3535.3333.0732.9830.1515.42
Revenue Growth-10.42%-12.6%-8.21%51.66%67.97%6.83%0.28%9.39%95.55%-
Gross Profit42.5243.4950.1062.2939.0822.3018.8922.6421.0412.05
Operating Income-2.25-60.08-37.83-7.55-14.42-6.26-9.01-4.94-6.45-8.61
Net Income-8.22-70.10-52.41-19.49-2.17-10.51-12.69-7.71-3.01-19.47
Shares Outstanding13.1611.741.511.060.750.500.380.350.320.27
Earnings Per Share-0.63-5.97-34.76-18.46-2.88-21.12-33.60-21.60-9.60-73.20
Operating Cash Flow-0.411.21-0.54-14.41-9.10-7.32-4.89-10.79-7.36-8.37
Capital Expenditures-0.54-0.37-1.61-5.82-0.60-0.30-0.69-1.84-1.10-0.82
Free Cash Flow-0.960.85-2.15-20.22-9.70-7.62-5.59-12.63-8.46-9.19
Cash & Equivalents5.246.802.862.586.374.473.054.930.750.33
Total Debt78.5478.5713913111120.9916.6814.928.392.47
Net Cash / Debt-73.30-71.77-136-128-104-16.53-13.63-10.00-7.64-2.14
Assets43.1646.4210614414127.9528.8834.5023.1715.76
Liabilities87.3690.1916415113235.7332.7230.2617.6716.38
Book Value-44.21-43.77-58.70-7.078.88-7.77-3.844.235.50-0.62
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Xtant Medical Holdings, Inc.
Country United States
Employees 141
CEO Sean E. Browne

Stock Information

Ticker Symbol XTNT
Stock Exchange NYSE American
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSEAMERICAN: XTNT

Description

Xtant Medical Holdings develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DMB Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation system; Spider cervical plating system; Axle Interspinous Fusion System; Silex Sacroiliac joint fusion system; Xpress minimally invasive pedicle screw system; and Fortex Pedicle screw system. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.